These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 18269675

  • 1. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S.
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular approaches for new vaccines against allergy.
    Niederberger V, Valenta R.
    Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
    [Abstract] [Full Text] [Related]

  • 5. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomés A.
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [Abstract] [Full Text] [Related]

  • 6. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R.
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [Abstract] [Full Text] [Related]

  • 7. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F.
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
    Asturias JA, Ibarrola I, Arilla MC, Vidal C, Ferrer A, Gamboa PM, Viñuela JE, Sanz ML, Andreu C, Martínez A.
    Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M, Swoboda I, Marth K, Valenta R.
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [Abstract] [Full Text] [Related]

  • 13. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B, Mothes-Luksch N, Vrtala S, Kneidinger M, Valent P, Valenta R.
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [Abstract] [Full Text] [Related]

  • 14. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL, Singh MB.
    Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
    [Abstract] [Full Text] [Related]

  • 15. Latex allergy: a model for therapy.
    Rolland JM, O'Hehir RE.
    Clin Exp Allergy; 2008 Jun; 38(6):898-912. PubMed ID: 18498539
    [Abstract] [Full Text] [Related]

  • 16. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recombinant allergens for immunotherapy.
    Valenta R, Niederberger V.
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.